BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29205636)

  • 1. Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy.
    Enninga EAL; Harrington SM; Creedon DJ; Ruano R; Markovic SN; Dong H; Dronca RS
    Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29205636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal soluble PD-1 levels are significantly increased in women with preeclampsia.
    Gu Y; Morgan J; Lewis DF; Cooper DB; McCathran CE; Wang Y
    Am J Reprod Immunol; 2020 Jan; 83(1):e13193. PubMed ID: 31585483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum soluble programmed cell death ligand-1 level as a potential biomarker for missed miscarriage.
    Li Q; Chen C; Wu J; Poon LC; Wang CC; Li TC; Zhang T; Guo X; Song L; Wang X; Zhang Q; Ye Z; Yang Y; Lu J; Yao J; Ye D; Wang Y
    Hum Reprod; 2023 Nov; 38(11):2128-2136. PubMed ID: 37671597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
    Okuyama M; Mezawa H; Kawai T; Urashima M
    Front Immunol; 2019; 10():86. PubMed ID: 30833943
    [No Abstract]   [Full Text] [Related]  

  • 5. High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer.
    Okuma Y; Hosomi Y; Nakahara Y; Watanabe K; Sagawa Y; Homma S
    Lung Cancer; 2017 Feb; 104():1-6. PubMed ID: 28212990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble immune checkpoints CTLA-4, HLA-G, PD-1, and PD-L1 are associated with endometriosis-related infertility.
    Santoso B; Sa'adi A; Dwiningsih SR; Tunjungseto A; Widyanugraha MYA; Mufid AF; Rahmawati NY; Ahsan F
    Am J Reprod Immunol; 2020 Oct; 84(4):e13296. PubMed ID: 32593225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
    Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
    J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
    Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
    Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.
    Sideras K; de Man RA; Harrington SM; Polak WG; Zhou G; Schutz HM; Pedroza-Gonzalez A; Biermann K; Mancham S; Hansen BE; Bart Takkenberg R; van Vuuren AJ; Pan Q; Ijzermans JNM; Sleijfer S; Sprengers D; Dong H; Kwekkeboom J; Bruno MJ
    Sci Rep; 2019 Jul; 9(1):10677. PubMed ID: 31337865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients.
    El-Gebaly F; Abou-Saif S; Elkadeem M; Helmy A; Abd-Elsalam S; Yousef M; Elkhouly RA; Amer IF; El-Demerdash T
    Curr Cancer Drug Targets; 2019; 19(11):896-905. PubMed ID: 31538897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    Li Y; Cui X; Yang YJ; Chen QQ; Zhong L; Zhang T; Cai RL; Miao JY; Yu SC; Zhang F
    Clin Breast Cancer; 2019 Oct; 19(5):326-332.e1. PubMed ID: 31176611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
    Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
    Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
    Luo L; Shu M; Li S; Cai Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.
    Kushlinskii NE; Alferov AA; Boulytcheva IV; Timofeev YS; Korotkova EA; Khvan OT; Kuzmin YB; Kuznetsov IN; Bondarev AV; Shchupak MY; Sokolov NY; Efimova MM; Gershtein ES; Sushentsov EA; Aliev MD; Musaev ER
    Klin Lab Diagn; 2020 Dec; 65(11):669-675. PubMed ID: 33301655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early transient suppression of immune checkpoint proteins T-cell immunoglobulin mucin-3 and programmed cell death-1 in peripheral blood lymphocytes after blastocyst transfer is associated with successful implantation.
    Zhang T; Zhu W; Zhao Y; Cheung WC; Liu Y; Chen X; Du Y; Leung KT; Chan YL; Wang CC; Laird S; Li TC
    Fertil Steril; 2020 Aug; 114(2):426-435. PubMed ID: 32199622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The content of the soluble forms PD-1 and PD-L1 in blood serum of patients with gastric cancer and their relationship with clinical and morphological characteristics of the disease.].
    Gershtein ES; Ognerubov NA; Chang VL; Delektorskaya VV; Korotkova EA; Sokolov NY; Polikarpova SB; Stilidi IS; Kushlinskii NE
    Klin Lab Diagn; 2020; 65(6):347-352. PubMed ID: 32459892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
    Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
    BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function.
    Zhang YH; Aldo P; You Y; Ding J; Kaislasuo J; Petersen JF; Lokkegaard E; Peng G; Paidas MJ; Simpson S; Pal L; Guller S; Liu H; Liao AH; Mor G
    J Leukoc Biol; 2020 Sep; 108(3):983-998. PubMed ID: 32386458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.